Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 18,900
- Avg volume
- 61,996
- Day's range
- $0.04 – $0.04
- Shares out
- —
- Stochastic %K
- 48%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
The More Life Company Corp., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs....
Show more
The More Life Company Corp., a biotech company, focuses on advancing solutions to optimize human, animal, and plant health in Canada. The company offers Quicksome which uses proprietary formulations and stabilizing agents to encapsulate active ingredients and optimizing delivery in pharmaceutical and nutraceutical applications; and Quicksol that enhances solubility for previously insoluble macrocyclic lactone drugs. It also provides licensed Agrarius, an agricultural plant signalling technology. The company was formerly known as Mountain Valley MD Holdings Inc. and changed its name to The More Life Company Corp. in August 2026. The company is headquartered in Concord, Canada.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 647-725-9755
- Website
- https://www.themorelife.company
- Address
- 260 Edgeley Boulevard, Unit 4 Vaughan, Concord, Canada
Latest news
No headlines yet.
Stocktwits
10xSniper
Oct 3, 2:03 AM
$MLCO.CSE
$TMLCF 🌱 Brazil potato: G12 Agro (independent), randomized block design, +32.5% special-grade yield. CEO: more Agrarius results coming. 2 positive 2026 trials. Commercial data building.
0 replies
10xSniper
Oct 1, 11:08 AM
$MLCO.CSE
$MLCO.CSE
$TMLCF 🥔 Company estimate from the Brazil trial: about USD 4,400/ha extra gross crop value with Agrarius post-emergence. Total yield +27.6% vs. control, randomized block design.
0 replies
10xSniper
Sep 30, 8:52 AM
$MLCO.CSE
$MLCO $TMLCF 🌱 Three Agrarius crop studies, three positive outcomes: potato (2025 +18.5%), corn (+23%), potato again (2026 +32.5%). CEO: "one of several results we expect to report over the coming months." DYOR. #MLCO #Agrarius
0 replies
10xSniper
Sep 29, 9:51 PM
$MLCO.CSE
$MLCO.CSE
$TMLCF 🌱💊 Two datasets in 7 days. Sept 15: independent G12 Agro Brazil trial, Agrarius +32.5% special-grade potato yield. Sept 22: exploratory human study, Quicksome testosterone in circulation in 10 to 30 min
0 replies
10xSniper
Sep 27, 9:02 AM
$MLCO.CSE
$TMLCF 🌱 Two independent scientific validations in 7 days: Brazil potato +32.5% (Sept 15) + human testosterone PK (Sept 22). Agri + Human Health. Field + clinical. Third-party validated both.
0 replies
10xSniper
Sep 9, 2:58 AM
$MLCO.CSE
$MLCO $TMLCF 🧬 Retatrutide + BPC-157 + GHK-Cu + KPV + SNAP-8 all formulated in Quicksome. GLP market
$150B+ by 2030. Sublingual delivery removes needle + cold chain. All legally compoundable now
0 replies
